ALNY
Price
$452.32
Change
-$1.86 (-0.41%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
59.29B
56 days until earnings call
SLXN
Price
$7.74
Change
+$0.48 (+6.61%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
5.66M
Interact to see
Advertisement

ALNY vs SLXN

Header iconALNY vs SLXN Comparison
Open Charts ALNY vs SLXNBanner chart's image
Alnylam Pharmaceuticals
Price$452.32
Change-$1.86 (-0.41%)
Volume$4.97K
Capitalization59.29B
Silexion Therapeutics
Price$7.74
Change+$0.48 (+6.61%)
Volume$300
Capitalization5.66M
ALNY vs SLXN Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. SLXN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a StrongBuy and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ALNY: $452.33 vs. SLXN: $7.74)
Brand notoriety: ALNY and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 58% vs. SLXN: 35%
Market capitalization -- ALNY: $59.29B vs. SLXN: $5.66M
ALNY [@Biotechnology] is valued at $59.29B. SLXN’s [@Biotechnology] market capitalization is $5.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, ALNY is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 2 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • ALNY’s TA Score: 2 bullish, 5 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а -3.26% price change this week, while SLXN (@Biotechnology) price change was +13.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

ALNY is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($59.3B) has a higher market cap than SLXN($5.66M). ALNY YTD gains are higher at: 92.227 vs. SLXN (-74.345). SLXN has higher annual earnings (EBITDA): -17.81M vs. ALNY (-170.84M). ALNY has more cash in the bank: 2.86B vs. SLXN (3.47M). SLXN has less debt than ALNY: SLXN (3.7M) vs ALNY (1.3B). ALNY has higher revenues than SLXN: ALNY (2.46B) vs SLXN (0).
ALNYSLXNALNY / SLXN
Capitalization59.3B5.66M1,047,888%
EBITDA-170.84M-17.81M959%
Gain YTD92.227-74.345-124%
P/E RatioN/AN/A-
Revenue2.46B0-
Total Cash2.86B3.47M82,458%
Total Debt1.3B3.7M35,073%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
9
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 1 day ago
10%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
27%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 1 day ago
30%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 1 day ago
27%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 1 day ago
52%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 1 day ago
53%
Declines
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 8 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 4 days ago
38%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VSGX67.890.24
+0.35%
Vanguard ESG International Stock ETF
SOYB22.310.05
+0.24%
Teucrium Soybean Fund
RTRE25.200.06
+0.23%
Rareview Total Return Bond ETF
HAPS30.99N/A
N/A
Harbor Human Capital Factor US Sm CapETF
XRT85.31-0.78
-0.91%
SPDR® S&P Retail ETF